Clinical Trial Update: A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 study of etelcalcetide in children with secondary hyperparathyroidism receiving hemodialysis, and it is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• Parsabiv (etelcalcetide)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism | Phase 3 | Status: RECRUITING